Year: 2026

Press Release
Nokia to provide intelligent connectivity for Finnish Border Guard counter-drone initiative nationwide

The U.S. Cloud Discovery Market is Expected to Grow from $0.60 Billion in 2025 to $3.06 Billion by 2035, While Europe is Projected to Expand from $0.39 Billion to $1.42 Billion, Fueled by Rising Multi-Cloud Complexity, Strong Cloud Security Investments, and Regulatory Requirements Including GDPR, NIS2, and DORA Across Enterprise Environments

The U.S. Cloud Discovery Market is Expected to Grow from $0.60 Billion in 2025 to $3.06 Billion by 2035, While Europe is Projected to Expand from $0.39 Billion to $1.42 Billion, Fueled by Rising Multi-Cloud Complexity, Strong Cloud Security Investments, and Regulatory Requirements Including GDPR, NIS2, and DORA Across Enterprise Environments

The U.S. Breast Cancer Liquid Biopsy Market is projected to grow from USD 0.39 Billion in 2025 to USD 0.84 Billion by 2035, while Europe is expected to expand from USD 0.35 Billion to USD 0.78 Billion, driven by increasing companion diagnostic adoption, expanding precision oncology programs, and growing utilization of ctDNA testing.

The U.S. Breast Cancer Liquid Biopsy Market is projected to grow from USD 0.39 Billion in 2025 to USD 0.84 Billion by 2035, while Europe is expected to expand from USD 0.35 Billion to USD 0.78 Billion, driven by increasing companion diagnostic adoption, expanding precision oncology programs, and growing utilization of ctDNA testing.

FORM 8.3

FORM 8.3

Wolters Kluwer today reports that it has repurchased 126,900 of its own ordinary shares in the period from June 18, 2026, up to and including June 24, 2026

Atos retenu sur trois lots du marché AMOA SI de la Centrale d’Achat de l’Informatique Hospitalière (CAIH)

San Francisco, CA, June 25, 2026 (GLOBE NEWSWIRE) — A new class action lawsuit filed in federal court alleges that Roblox Corporation built a multi-billion-dollar business model on unpaid and underpaid child labor.

STOCKHOLM, Sweden, June 25, 2026 – AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, today announced the publication in The Lancet of results from its Phase 1b/2a GOAL-HF1 study evaluating AC01, a first-in-class, oral calcium-sensitising contractile agent, in patients with heart failure with reduced ejection fraction (HFrEF). The results showed a favourable safety and tolerability profile, dose-proportional pharmacokinetics with confirmed target engagement. In exploratory efficacy analyses, numerical rapid and sustained improvements in haemodynamics and cardiac structure and function were observed on top of optimised guideline-directed medical therapy (GDMT).

Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization

KNL, owned by Telenor Group, has been appointed as an approved supplier on the United Kingdom’s Tactical Communication Systems Framework

(Fornebu, Norge / Oulu, Finland, 25. juni 2026) KNL, et datterselskap av Telenor Group som leverer kommunikasjonssystemer til forsvarssektoren, er utpekt som godkjent leverandør under Storbritannias Tactical Communication Systems Framework (RM6393).

New CoinShares survey of 261 advisers across five markets finds that firm policy, not knowledge or client demand, determines whether crypto exposure is managed, or invisible 

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) — Alpex Acquisition Corporation (NASDAQ: ALPXU) (“Alpex”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under “ALPXU” beginning June 25, 2026. Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon consummation of an initial business combination. Each whole redeemable warrant entitles the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share. Upon separate trading, the Class A ordinary shares, warrants and rights are expected to be listed on Nasdaq under “ALPX,” “ALPXW,” and “ALPXR,” respectively.

New York, N.Y., June 24, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced recent and upcoming high-profile engagements with government officials, industry leaders, multilateral organizations, and energy stakeholders across Asia, Africa, Latin America, and the Caribbean as well as a management team update.

DENVER and MIAMI, June 24, 2026 (GLOBE NEWSWIRE) — The Western Union Company (“Western Union”) (NYSE: WU) and International Money Express, Inc. (“Intermex”) (NASDAQ: IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to obtain the final regulatory approval. Western Union and Intermex anticipate closing the transaction as soon as reasonably practicable upon receipt of such approval as well as satisfaction of other customary closing conditions.

NINGDE, China, June 24, 2026 (GLOBE NEWSWIRE) — Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today provided an update regarding the decision of the Nasdaq Hearings Panel (the “Panel”) to delist the Company’s ordinary shares from The Nasdaq Capital Market.